Form 4: Pfizer Director Receives Stock Grant
Insider Transaction (Form 4)
Shantanu Narayen, a Director of Pfizer Inc, received 1,744 shares of common stock on September 25, 2026.
Summary
- Grant/award: acquired 1,744 Phantom Stock Units at $28.67 ($50,000) on September 25, 2026; holds 205,649 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Shantanu Narayen — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-25 | Grant/award | Phantom Stock Units | 1,743.983 | $29 | $50.0K | 205,648.823 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-25 | Grant/award (1,744 shares) |
Keywords
insider transaction, Form 4, PFE, PFIZER INC, neutral, Shantanu Narayen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.